https://www.selleckchem.com/pr....oducts/ziftomenib.ht
These findings highlight the potential for increased vulnerability of PCa patients to COVID-19.Human cytomegalovirus (HCMV) is a ubiquitous opportunistic pathogen and can be life-threatening for immunocompromised individuals. There is currently no available vaccine for the prevention of HCMV- associated diseases and most of the available antiviral drugs that target viral DNA synthesis become ineffective in treating HCMV mutants that arise after long-term use in immunocompromised patients. Here, we examined the effects of Eltanexor, a
Like
Comment
Share
